Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

57 trials with published results (11%)

Research Maturity

309 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.9%

15 terminated out of 520 trials

Success Rate

95.4%

+8.8% vs benchmark

Late-Stage Pipeline

31%

162 trials in Phase 3/4

Results Transparency

18%

57 of 309 completed with results

Key Signals

57 with results95% success15 terminated

Data Visualizations

Phase Distribution

434Total
Not Applicable (150)
Early P 1 (2)
P 1 (71)
P 2 (49)
P 3 (88)
P 4 (74)

Trial Status

Completed309
Unknown103
Recruiting37
Not Yet Recruiting19
Withdrawn18
Active Not Recruiting15

Trial Success Rate

95.4%

Benchmark: 86.5%

Based on 309 completed trials

Clinical Trials (520)

Showing 20 of 20 trials
NCT06397612Not ApplicableActive Not Recruiting

Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.

NCT06397625Not ApplicableActive Not RecruitingPrimary

Treatment With Peripheral Nerve Stimulation of the Pudendal Nerve in Patients With Erectile Dysfunction

NCT05232279Phase 3Active Not RecruitingPrimary

Effect of Testofen on Erectile Function in an Adult Male Population

NCT06489431Phase 3Active Not RecruitingPrimary

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

NCT04349059Not ApplicableRecruitingPrimary

The Impact of Dietary Pattern on Erectile Function

NCT06167733Not ApplicableActive Not RecruitingPrimary

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

NCT07719790Not Yet Recruiting

Does Erectile Dysfonction Allow to Evaluate Subendocardial Viability Among Treated Patients With Hypertension ?

NCT07715448Phase 4Completed

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

NCT06805513Phase 3CompletedPrimary

Actual Use Trial of Tadalafil 5 mg

NCT04200937Enrolling By InvitationPrimary

IT Matters: The Erectile Restoration Registry

NCT07048314Phase 1RecruitingPrimary

Stem Cells for Erectile Dysfunction Post RALP

NCT07692867Phase 3CompletedPrimary

Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction

NCT07685249Not ApplicableNot Yet Recruiting

Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment

NCT07676617Active Not RecruitingPrimary

Satisfaction of Patients With Erectile Dysfunction With the Use of Sildenafil Oral Suspension Compared to Orodispersible Tablets

NCT07668973Not ApplicableNot Yet Recruiting

Comparison Between Excision And Primary Anastomosis Urethroplasty And Tunica Vaginalis Graft Urethroplasty.

NCT03849586Active Not RecruitingPrimary

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

NCT07642505Phase 4RecruitingPrimary

L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction

NCT07451808Not ApplicableNot Yet RecruitingPrimary

Male Pelvic Floor Muscle Rehabilitation Exercises

NCT07460167Not ApplicableCompletedPrimary

Penile Rehabilitation in Patients With Erectile Dysfunction After Pelvic Fracture Urethral Injury Using Low-intensity Shock Wave.

NCT07627477Active Not Recruiting

Impact of Depression Severity on Sexual Dysfunction

Scroll to load more

Research Network

Activity Timeline